0000874015-17-000061.txt : 20171017 0000874015-17-000061.hdr.sgml : 20171017 20171017173617 ACCESSION NUMBER: 0000874015-17-000061 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20171013 FILED AS OF DATE: 20171017 DATE AS OF CHANGE: 20171017 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Geary Richard S CENTRAL INDEX KEY: 0001442730 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19125 FILM NUMBER: 171141368 MAIL ADDRESS: STREET 1: C/O ISIS PHARMACEUTICALS, INC. STREET 2: 2855 GAZELLE COURT CITY: CARLSBAD STATE: CA ZIP: 92010 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: IONIS PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000874015 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 330336973 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2855 GAZELLE COURT CITY: CARLSBAD STATE: CA ZIP: 92010 BUSINESS PHONE: 7609319200 MAIL ADDRESS: STREET 1: 2855 GAZELLE COURT CITY: CARLSBAD STATE: CA ZIP: 92010 FORMER COMPANY: FORMER CONFORMED NAME: ISIS PHARMACEUTICALS INC DATE OF NAME CHANGE: 19930328 4 1 edgar.xml PRIMARY DOCUMENT X0306 4 2017-10-13 0000874015 IONIS PHARMACEUTICALS INC IONS 0001442730 Geary Richard S C/O IONIS PHARMACEUTICALS, INC. 2855 GAZELLE COURT CARLSBAD CA 92010 0 1 0 0 SVP, Development Common Stock 2017-10-13 2017-10-13 4 S 0 807 60.00 D 12351 D Common Stock 2017-10-13 2017-10-13 4 M 0 426 10.29 A 12777 D Common Stock 2017-10-13 2017-10-13 4 S 0 426 60.00 D 12351 D Common Stock 2017-10-13 2017-10-13 4 M 0 7035 7.25 A 19386 D Common Stock 2017-10-13 2017-10-13 4 S 0 7035 60.00 D 12351 D Employee Stock Option (right to buy) 10.29 2017-10-13 2017-10-13 4 M 0 426 0 D 2015-01-03 2018-01-02 Common Stock 426 0 D Employee Stock Option (right to buy) 7.25 2017-10-13 2017-10-13 4 M 0 7035 0 D 2016-01-03 2019-01-02 Common Stock 7035 0 D The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 12/2/2016. Acquired as a result of exercising a stock option pursuant to Rule 10b5-1 Trading Plan. The purchase and sale reported on this Form 4 was effective pursuant to Rule 10b5-1 Trading Plan adopted by the reporting person on 12/2/2016. /s/B. Lynne Parshall, attorney-in-fact 2017-10-17